Cargando…

Therapy and prevention of gastric ulcer.

After establishing the benign nature of a gastric ulcer, the treatment is primarily medical. This medical therapy is aimed to alleviate symptoms, to heal the ulcer and to prevent relapses. Based on the history of non-steroidal anti-inflammatory drugs (NSAIDs) and the Helicobacter pylori-status, gast...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamers, C. B., Biemond, I., Masclee, A. A., Veenendaal, R. A.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589011/
https://www.ncbi.nlm.nih.gov/pubmed/9165695
_version_ 1782161036698189824
author Lamers, C. B.
Biemond, I.
Masclee, A. A.
Veenendaal, R. A.
author_facet Lamers, C. B.
Biemond, I.
Masclee, A. A.
Veenendaal, R. A.
author_sort Lamers, C. B.
collection PubMed
description After establishing the benign nature of a gastric ulcer, the treatment is primarily medical. This medical therapy is aimed to alleviate symptoms, to heal the ulcer and to prevent relapses. Based on the history of non-steroidal anti-inflammatory drugs (NSAIDs) and the Helicobacter pylori-status, gastric ulcer patients can be divided into four categories (1) H. pylori positive plus NSAID-use, (2) H. pylori positive without NSAID use, (3) NSAID use with negative H. pylori-status, (4) Negative H. pylori-status and no NSAID use. Patients taking NSAIDs should stop this therapy if possible. Patients with gastric H. pylori infection should be treated by a regimen of a proton pump inhibitor with at least two appropriate antibiotics. This treatment will result in early alleviation of symptoms, rapid healing of the ulcer and prophylaxis of ulcer relapse. In patients with gastric ulcer who cannot stop NSAIDs, maintenance therapy with prostaglandins or potent antisecretory drugs should be considered. The few patients with gastric ulcer who do not take NSAIDs and do not have gastric H. pylori infection should be treated by antisecretory drugs, and they should be carefully followed endoscopically to exclude malignant (carcinoma, lymphoma) or non-peptic (Crohn's disease) disease. All patients with gastric ulcer should be re-endoscoped to verify complete ulcer healing. Surgery may be considered in gastric ulcer patients with complications, in those with severe dysplasia of the gastric mucosa, and in those who are not able or willing to take the medication.
format Text
id pubmed-2589011
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Yale Journal of Biology and Medicine
record_format MEDLINE/PubMed
spelling pubmed-25890112008-12-01 Therapy and prevention of gastric ulcer. Lamers, C. B. Biemond, I. Masclee, A. A. Veenendaal, R. A. Yale J Biol Med Research Article After establishing the benign nature of a gastric ulcer, the treatment is primarily medical. This medical therapy is aimed to alleviate symptoms, to heal the ulcer and to prevent relapses. Based on the history of non-steroidal anti-inflammatory drugs (NSAIDs) and the Helicobacter pylori-status, gastric ulcer patients can be divided into four categories (1) H. pylori positive plus NSAID-use, (2) H. pylori positive without NSAID use, (3) NSAID use with negative H. pylori-status, (4) Negative H. pylori-status and no NSAID use. Patients taking NSAIDs should stop this therapy if possible. Patients with gastric H. pylori infection should be treated by a regimen of a proton pump inhibitor with at least two appropriate antibiotics. This treatment will result in early alleviation of symptoms, rapid healing of the ulcer and prophylaxis of ulcer relapse. In patients with gastric ulcer who cannot stop NSAIDs, maintenance therapy with prostaglandins or potent antisecretory drugs should be considered. The few patients with gastric ulcer who do not take NSAIDs and do not have gastric H. pylori infection should be treated by antisecretory drugs, and they should be carefully followed endoscopically to exclude malignant (carcinoma, lymphoma) or non-peptic (Crohn's disease) disease. All patients with gastric ulcer should be re-endoscoped to verify complete ulcer healing. Surgery may be considered in gastric ulcer patients with complications, in those with severe dysplasia of the gastric mucosa, and in those who are not able or willing to take the medication. Yale Journal of Biology and Medicine 1996 /pmc/articles/PMC2589011/ /pubmed/9165695 Text en
spellingShingle Research Article
Lamers, C. B.
Biemond, I.
Masclee, A. A.
Veenendaal, R. A.
Therapy and prevention of gastric ulcer.
title Therapy and prevention of gastric ulcer.
title_full Therapy and prevention of gastric ulcer.
title_fullStr Therapy and prevention of gastric ulcer.
title_full_unstemmed Therapy and prevention of gastric ulcer.
title_short Therapy and prevention of gastric ulcer.
title_sort therapy and prevention of gastric ulcer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589011/
https://www.ncbi.nlm.nih.gov/pubmed/9165695
work_keys_str_mv AT lamerscb therapyandpreventionofgastriculcer
AT biemondi therapyandpreventionofgastriculcer
AT mascleeaa therapyandpreventionofgastriculcer
AT veenendaalra therapyandpreventionofgastriculcer